Macquarie Group’s Orthofix Medical OFIX Stock Holding History

Macquarie Group’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,505	Closed	-$67K	–	2002
2022 Q3	$67K	Hold	3,505	–	–	﹤0.01%	1870
2022 Q2	$83K	Hold	3,505	–	–	﹤0.01%	1916
2022 Q1	$115K	Hold	3,505	–	–	﹤0.01%	1916
2021 Q4	$109K	Hold	3,505	–	–	﹤0.01%	1913
2021 Q3	$134K	Hold	3,505	–	–	﹤0.01%	1883
2021 Q2	$141K	Buy	+3,505	New	+$148K	﹤0.01%	1870
2018 Q4	–	Sell	-418	Closed	-$24K	–	2317
2018 Q3	$24K	Sell	418 -5,740	-93%	-$322K	﹤0.01%	1869
2018 Q2	$350K	Sell	6,158 -2,503	-29%	-$143K	﹤0.01%	1473
2018 Q1	$509K	Sell	8,661 -2,778	-24%	-$156K	﹤0.01%	1384
2017 Q4	$626K	Sell	11,439 -2,400	-17%	-$124K	﹤0.01%	1371
2017 Q3	$654K	Buy	+13,839	New	+$652K	﹤0.01%	1347
2014 Q1	–	Sell	-30,000	Closed	-$685K	–	1568
2013 Q4	$685K	Hold	30,000	–	–	﹤0.01%	1220
2013 Q3	$626K	Buy	+30,000	New	+$728K	﹤0.01%	1256

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Macquarie Group's OFIX Position: Q4 2022 in Review

Macquarie Group sold out of Orthofix Medical (OFIX) in Q4 2022, closing a stake of 3,505 shares — an estimated $67K sold.

Macquarie Group first reported a position in OFIX in Q3 2013 and held it in 13 quarters. The position peaked at $685K in Q4 2013. 153 funds tracked by Wall St. Rank hold OFIX as of Q4 2022.

Macquarie Group reported no remaining Orthofix Medical position as of Q4 2022 after selling out during the quarter.
Macquarie Group sold 3,505 Orthofix Medical shares in Q4 2022, an estimated $67K.
Macquarie Group first reported a position in Orthofix Medical in Q3 2013 and held it in 13 quarters.
Macquarie Group's Orthofix Medical position peaked at $685K in Q4 2013.
153 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.